With diabetes being a complex health condition, finding a cure for it naturally comes with quite a few challenges. However, scientists have recently made a huge breakthrough regarding the search for a cure by purging mice of the debilitating illness. This puts them one step closer to finally ending the suffering of thousands around the world who are living with diabetes every day.
Now, it’s worth noting that the study is still in its very early stages and there is still a lot of work to be done. However, it is encouraging to know that UT Health San Antonio researchers finally found a way to improve insulin secretion, which could potentially end insulin-dependency by diabetics, Futurism reports.
The researchers have tested their new method on lab mice that were afflicted with the disease and the rodents were cured. For one year, the subjects exhibited no symptoms to indicate that the cure did not work. Dr. Bruno Doiron, one of the researchers behind the project said as much.
“It worked perfectly,” Dr. Doiron said. “We cured mice for one year without any side effects. That’s never been seen. But it’s a mouse model, so caution is needed. We want to bring this to large animals that are closer to humans in physiology of the endocrine system.”
As a result, the researchers are now thinking about moving the cure to human trials over the next three years. That might seem like a lifetime, but it’s much closer than anyone has ever been to rid the world of diabetes.
It would seem that the obstacles won’t be much of an issue either since it would appear that the Food and Drug Administration has granted approval to similar cases in the past, News.com.au reports. If so, the world should be on track to becoming free of diabetes in the next decade or so.


Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
China vs. NASA: The New Moon Race and What's at Stake by 2030
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 



